“…Although the study design benefits from minimising many limitations associated with observational databases, the sample size is informed using UK Biobank genetic data derived from just two racial backgrounds, with more than 93% of women with British or Irish white race. 17 We cannot exclude that IL-1 signaling by IL-1Ra influences the quality of analgesia, but we will be able to rule out that IL-1Ra signaling impacts upon potential confounders such as duration of labour. 28 Induction of labour will likely be common in labouring women requesting epidural analgesia, so a planned subgroup analysis will assess whether there is any relationship between induction of labour and the study exposure of interest and/or outcomes.…”
Section: Discussionmentioning
confidence: 97%
“…13 Our previous analysis of over 250,000 women from the UK Biobank showed that approximately 11% of UK white women have a zero genetic (allele) score for IL-1Ra (i.e., the lowest genetically determined amount of IL1-ra). 17 The overall incidence of ERMF in EPIFEVER was 13.4%. 25 Our original sample size estimate was based on the single outcome of ERMF-(temperature > 38ºC), assuming that women with 0-1 allele scores are more likely to develop temperature > 38ºC (approximately 22%) compared with with IL-1Ra allele scores >1.…”
Section: Sample Sizementioning
confidence: 94%
“…16 Mendelian randomisation analysis of UK Biobank data suggests that genetic IL-1ra levels are associated with a reduced risk of an unplanned caesarean section after the onset of labour; this association is disrupted by the use of neuraxial analgesia. 17 In EPIFEVER-2 trial, we hypothesise that the absence of rs6743376 and rs1542176 alleles for IL1-ra, which results in the lowest circulating levels of IL-1ra, are associated with ERMF and/or the administration of intrapartum antibiotics (Figure 1).…”
“…Although the study design benefits from minimising many limitations associated with observational databases, the sample size is informed using UK Biobank genetic data derived from just two racial backgrounds, with more than 93% of women with British or Irish white race. 17 We cannot exclude that IL-1 signaling by IL-1Ra influences the quality of analgesia, but we will be able to rule out that IL-1Ra signaling impacts upon potential confounders such as duration of labour. 28 Induction of labour will likely be common in labouring women requesting epidural analgesia, so a planned subgroup analysis will assess whether there is any relationship between induction of labour and the study exposure of interest and/or outcomes.…”
Section: Discussionmentioning
confidence: 97%
“…13 Our previous analysis of over 250,000 women from the UK Biobank showed that approximately 11% of UK white women have a zero genetic (allele) score for IL-1Ra (i.e., the lowest genetically determined amount of IL1-ra). 17 The overall incidence of ERMF in EPIFEVER was 13.4%. 25 Our original sample size estimate was based on the single outcome of ERMF-(temperature > 38ºC), assuming that women with 0-1 allele scores are more likely to develop temperature > 38ºC (approximately 22%) compared with with IL-1Ra allele scores >1.…”
Section: Sample Sizementioning
confidence: 94%
“…16 Mendelian randomisation analysis of UK Biobank data suggests that genetic IL-1ra levels are associated with a reduced risk of an unplanned caesarean section after the onset of labour; this association is disrupted by the use of neuraxial analgesia. 17 In EPIFEVER-2 trial, we hypothesise that the absence of rs6743376 and rs1542176 alleles for IL1-ra, which results in the lowest circulating levels of IL-1ra, are associated with ERMF and/or the administration of intrapartum antibiotics (Figure 1).…”
“…5 Labor activates the release of cytokines, specifically IL-1β and concurrently a release of IL-1ra prevents the effects of IL-1-induced preterm labor. 5 As demonstrated by del Arroyo et al, there is a modulation of IL-1β and the receptor antagonist that takes place when tissue is exposed to bupivacaine. 6 Local anesthetics may favor the proinflammatory cytokines by the change in the IL-1ra/IL-1β ratio.…”
(Br J Anaesth. 2022;128:89–97)
Inflammation during labor can cause a host of complications that can in turn lead to emergency cesarean delivery due to increased risks to both mother and child. The body has natural responses to inflammation, one of which is the release of an anti-inflammatory cytokine, an interleukin-1 receptor antagonist (IL-1ra). The gene that encodes the expression of IL-1ra has 2 upstream alleles that increase mRNA expression and IL-1ra concentration. Previously in similar situations where genes have been identified and associated, Mendelian randomization techniques have been able to show causal relationships between the genes and observable outcomes.
“…The interleukin receptor antagonist (IL-1ra) directly inhibits the pro-inflammatory impacts of IL-1β. 5 Labor activates the release of cytokines, specifically IL-1β and concurrently a release of IL-1ra prevents the effects of IL-1-induced preterm labor. 5 As demonstrated by del Arroyo et al, there is a modulation of IL-1β and the receptor antagonist that takes place when tissue is exposed to bupivacaine.…”
(Int J Gynecol Obstet. 2022;157:283–288)
Postpartum hemorrhage (PPH) is one of the leading causes of maternal mortality. Carboprost is a 15-methyl F2a prostaglandin that induces uterine contractions and is recommended for PPH treatment. Carboprost has adverse side effects, the most prominent being nausea and vomiting. Propofol, when used at its subhypnotic dose, is known for reducing nausea and vomiting after chemotherapy treatment. This study aimed to show whether a steady administration of a subhypnotic dose of propofol prevents nausea and vomiting after carboprost is administered during cesarean delivery (CD).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.